SynthesisThe Lancet. Global health2023
Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study.
Synthesis in The Lancet. Global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 33 citations in OpenAlex.
- Review
- A Rise in Measles Reporting Two Years After the COVID-19 Pandemic: A Descriptive Analysis of Measles in Iraq in 2023 and Early 2024.International journal of environmental research and public health · 2026Article
- Spatiotemporal Dynamics of the 2025-2026 Measles Outbreak in Mexico: Jalisco as the Emerging Epicenter and the Impact of Intensive Immunization Efforts.Pathogens (Basel, Switzerland) · 2026Article
- Machine Learning-Based Severity Stratification for Smart Preventive Decision Support: Evidence from Measles Surveillance in a Resource-Constrained Region.Journal of clinical medicine · 2026Article
- The theory of epidemics with altruism.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- A large measles outbreak in Zimbabwe related to vaccine hesitancy in 2022.The Pan African medical journal · 2026Article
- Cost-effectiveness and budget impact analyses of strategies to improve measles vaccination coverage in Kenya.PLOS global public health · 2026Article
- Measles is resurging in the Americas and the world is watching.Nature reviews. Microbiology · 2025Article
- Article
- The challenge of protracted measles outbreaks in Kismayo, Somalia: A mixed-method investigation of measles burden and vaccination coverage during a 2020-2021 outbreak.PLOS global public health · 2025Article
- Measles outbreak investigation in Kakumiro District, Uganda, February-May 2024.Discover public health · 2025Article
- Estimating the optimal age for infant measles vaccination.Nature communications · 2024Article
- Progress Toward Measles Elimination - Worldwide, 2000-2023.MMWR. Morbidity and mortality weekly report · 2024Article
- Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.Vaccine · 2024Article
- Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001-2023.Vaccines · 2024Article
- An Upsurge of Measles Cases in Mali-a Consequence of Pandemic-associated Disruption in Routine Immunization.Open forum infectious diseases · 2024Article
- Descriptive Analysis of Measles Outbreak in Liberia, 2022.IJID regions · 2024Article
- Not only vaccine hesitancy, but also vaccination campaign hesitancy drives measles epidemics in conflict-torn eastern DR Congo.Conflict and health · 2024Article
- Suboptimal MMR Vaccination Coverages-A Constant Challenge for Measles Elimination in Romania.Vaccines · 2024Article
- Progress Toward Measles Elimination - Worldwide, 2000-2022.MMWR. Morbidity and mortality weekly report · 2023Article
Corrections and comments
- Commented on by
Authors and funding
9 authors at 5 institutions in 3 countries.
Funding
Abstract
backgroundTo understand the current measles mortality burden, and to mitigate the future burden, it is crucial to have robust estimates of measles case fatalities. Estimates of measles case-fatality ratios (CFRs) that are specific to age, location, and time are essential to capture variations in underlying population-level factors, such as vaccination coverage and measles incidence, which contribute to increases or decreases in CFRs. In this study, we updated estimates of measles CFRs by expanding upon previous systematic reviews and implementing a meta-regression model. Our objective was to use all information available to estimate measles CFRs in low-income and middle-income countries (LMICs) by country, age, and year.
methodsFor this systematic review and meta-regression modelling study, we searched PubMed on Dec 31, 2020 for all available primary data published from Jan 1, 1980 to Dec 31, 2020, on measles cases and fatalities occurring up to Dec 31, 2019 in LMICs. We included studies that previous systematic reviews had included or which contained primary data on measles cases and deaths from hospital-based, community-based, or surveillance-based reports, including outbreak investigations. We excluded studies that were not in humans, or reported only data that were only non-primary, or on restricted populations (eg, people living with HIV), or on long-term measles mortality (eg, death from subacute sclerosing panencephalitis), and studies that did not include country-level data or relevant information on measles cases and deaths, or were for a high-income country. We extracted summary data on measles cases and measles deaths from studies that fitted our inclusion and exclusion criteria. Using these data and a suite of covariates related to measles CFRs, we implemented a Bayesian meta-regression model to produce estimates of measles CFRs from 1990 to 2019 by location and age group. This study was not registered with PROSPERO or otherwise.
findingsWe identified 2705 records, of which 208 sources contained information on both measles cases and measles deaths in LMICS and were included in the review. Between 1990 and 2019, CFRs substantially decreased in both community-based and hospital-based settings, with consistent patterns across age groups. For people aged 0-34 years, we estimated a mean CFR for 2019 of 1·32% (95% uncertainty interval [UI] 1·28-1·36) among community-based settings and 5·35% (5·08-5·64) among hospital-based settings. We estimated the 2019 CFR in community-based settings to be 3·03% (UI 2·89-3·16) for those younger than 1 year, 1·63% (1·58-1·68) for age 1-4 years, 0·84% (0·80-0·87) for age 5-9 years, and 0·67% (0·64-0·70) for age 10-14 years.
interpretationAlthough CFRs have declined between 1990 and 2019, there are still large heterogeneities across locations and ages. One limitation of this systematic review is that we were unable to assess measles CFR among particular populations, such as refugees and internally displaced people. Our updated methodological framework and estimates could be used to evaluate the effect of measles control and vaccination programmes on reducing the preventable measles mortality burden.
fundingBill & Melinda Gates Foundation; Gavi, the Vaccine Alliance; and the US National Institutes of Health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.